These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 14667101)

  • 1. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
    Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
    Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus.
    Yamada Y; Nozawa K; Nakano S; Mitsuo Y; Hiruma K; Doe K; Sekigawa I; Yamanaka K; Takasaki Y
    Mod Rheumatol; 2016 Jul; 26(4):562-8. PubMed ID: 26667376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T; Hirata D; Onda K; Nara H; Minota S
    J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.
    Santer DM; Yoshio T; Minota S; Möller T; Elkon KB
    J Immunol; 2009 Jan; 182(2):1192-201. PubMed ID: 19124763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus.
    Yokoyama T; Fujii T; Kondo-Ishikawa S; Yamakawa N; Nakano M; Yukawa N; Yoshifuji H; Ohmura K; Mimori T
    Lupus; 2014 Jun; 23(7):635-42. PubMed ID: 24493282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
    Hirohata S; Sakuma Y; Matsueda Y; Arinuma Y; Yanagida T
    Clin Exp Rheumatol; 2018; 36(6):1003-1007. PubMed ID: 29846157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of clinical outcomes in patients with neuropsychiatric systemic lupus erythematosus.
    Ichinose K; Arima K; Umeda M; Fukui S; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Sato S; Origuchi T; Kawakami A
    Cytokine; 2016 Mar; 79():31-7. PubMed ID: 26745468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
    George-Chandy A; Trysberg E; Eriksson K
    Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
    Asano T; Ito H; Kariya Y; Hoshi K; Yoshihara A; Ugawa Y; Sekine H; Hirohata S; Yamaguchi Y; Sato S; Kobayashi H; Migita K; Ohira H; Hashimoto Y; Watanabe H
    PLoS One; 2017; 12(10):e0186414. PubMed ID: 29036223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
    Ichinose K; Arima K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nakajima H; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Motomura M; Kawakami A
    Clin Immunol; 2015 Apr; 157(2):114-20. PubMed ID: 25656641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.
    Horai Y; Watanabe H; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
    Fukuoka Igaku Zasshi; 2010 Feb; 101(2):34-40. PubMed ID: 20560477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus.
    Hu C; Huang W; Chen H; Song G; Li P; Shan Q; Zhang X; Zhang F; Zhu H; Wu L; Li Y
    PLoS One; 2015; 10(5):e0126643. PubMed ID: 25954975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.